Results 1,281-1,300 of 1,217,574 for in 'Dáil debates' OR in 'Committee meetings' (speaker:Tom Kitt OR speaker:Réada Cronin OR speaker:Simon Coveney OR speaker:Seán Sherlock OR speaker:Denise Mitchell OR speaker:Duncan Smith OR speaker:Fergus O'Dowd OR speaker:Michael Healy-Rae OR speaker:Jackie Cahill OR speaker:Niall Collins OR speaker:Mattie McGrath OR speaker:Michael Creed OR speaker:Pádraig O'Sullivan OR speaker:Éamon Ó Cuív OR speaker:Mick Barry OR speaker:David Cullinane OR speaker:Dessie Ellis OR speaker:Pauline Tully OR speaker:Paul Donnelly OR speaker:Joe Flaherty OR speaker:Neasa Hourigan OR speaker:Stephen Donnelly OR speaker:Mark Ward OR speaker:Neale Richmond OR speaker:Pat Buckley OR speaker:Norma Foley OR speaker:Bernard Durkan OR speaker:Ruairi Ó Murchú OR speaker:Johnny Mythen OR speaker:Catherine Connolly OR speaker:Aindrias Moynihan OR speaker:Niamh Smyth OR speaker:Claire Kerrane OR speaker:Pearse Doherty OR speaker:Anne Rabbitte OR speaker:Mary Lou McDonald OR speaker:John Lahart OR speaker:Éamon Ó Cuív15 OR speaker:Éamon Ó Cuív58 OR speaker:Paul McAuliffe OR speaker:Jim O'Callaghan OR speaker:Simon Harris OR speaker:Helen McEntee OR speaker:Pádraig Mac Lochlainn OR speaker:Hildegarde Naughton OR speaker:Éamon Ó Cuív88 OR speaker:Patrick Costello OR speaker:Peadar Tóibín OR speaker:Danny Healy-Rae OR speaker:Peter Burke OR speaker:Maurice Quinlivan OR speaker:Marc MacSharry)

Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)

Bernard Durkan: I welcome the witnesses and thank them for giving of their time so readily. How do we compare with the rest of Europe in terms of ability to detect, diagnose and treat? That is my first question. Who is the best in Europe? Who is the worst?

Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)

Bernard Durkan: For instance, whose services should we try to match in order to improve our standards? Who is the best out there, even with the limited information we have available? Who-----

Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)

Bernard Durkan: How are patients identified? For example, can a patient living in Donegal, Kerry or the midlands rest assured that he or she will be detected on time and with sufficient scope for treatment and recovery?

Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)

Bernard Durkan: What is the best way to set about providing the data that would be helpful in dealing with this situation?

Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)

Bernard Durkan: Is that being set up at present? Can it be set up at present? Is it being encouraged? Is the ICS encouraging it or can it do so through the hospital system, GPs and so on?

Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)

Bernard Durkan: Is there a deficit in that area that is identifiable now, and within what timespan is it possible to address the issue?

Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)

Bernard Durkan: We need a strategy somewhat like the national cancer strategy of some years ago.

Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)

Bernard Durkan: As regards women's health, Professor McKeown mentioned that this apparently applies throughout Europe as well in terms of danger of heart attacks, cardiovascular failure, etc. What is being done in Europe now to address that issue, and what is being done here?

Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)

Bernard Durkan: Professor McKeown mentioned a treatment that is restricted at the moment. Why is it restricted? What is it?

Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)

Bernard Durkan: Could we have a comparison done between the older drug and its effectiveness and the new drug, and could we avail of that for the committee, Chairman? I think it would be useful, and it could be used further. Is that possible?

Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)

Bernard Durkan: I have a very short time left. Obviously a strategy is required. Within that strategy certain items, such as the availability of particular drugs that are effective, need to identified. The thing that comes to mind also is there are a number of people who are in danger of heart failure but do not know it for some unknown reason, so the degree to which the services are available for...

Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)

David Cullinane: I welcome our witnesses and thank them for the extensive briefing documents they submitted, as well as the opening statement and the asks they have of this committee. I will start with the national strategy because it is important. The most important point the witnesses made in their presentation is we do not have an overarching national strategy and have not for five years. Just for the...

Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)

David Cullinane: I thank Professor McAdam. I see many of the critical issues the witnesses identified are issues common to a lot of areas we are hearing about. One is the lack of comprehensive national registries. That seems to be a problem across a whole range of diseases. Do the witnesses think there would be a step-change in that if we moved to electronic medical records and digitising the health...

Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)

David Cullinane: I thank Professor McAdam. I move to diagnostics, because it is one of those areas in healthcare where the National Treatment Purchase Fund does not publish the diagnostic waiting lists or indeed community waiting lists, which it should. Very often we have to keep digging and asking parliamentary questions to get some sense of how bad they are. We know that in some cases they are not great....

Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)

David Cullinane: There is a business case that was developed by the national heart programme around cardiac imaging.

Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)

David Cullinane: I am taking it from Dr. Murphy's response that would be more insourcing and more public availability in the public service, as opposed to outsourcing. However, the fundamental point is more capacity.

Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)

David Cullinane: I thank Dr. Murphy. Our time is limited and I have one more question to put. An issue that is coming up a lot at this committee when we have witnesses before us is the recruitment embargo that was in place and the still very limited recruitment for 2024. The witnesses' opening statement refers to "... significant workforce issues including an embargo on filling vacant positions since...

Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)

David Cullinane: Just to let the Chair know, a health motion is being taken in the Dáil and some of us will have to leave to speak on it.

Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)

Neasa Hourigan: I will comment on some of the issues around the medicines management programme. For my own clarity, are these injections on cholesterol that we are talking about injections that would be undertaken by a clinician or is it something someone does at home?

Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)

Neasa Hourigan: Okay. That seems to be more prevalent across a number of treatments in healthcare at the moment. Regarding the medicine management programme, I can only imagine there is a huge amount of innovation in this area. If doctors want to move a treatment off the management programme and make it more freely available, how long is that process?